CN1665492A - 用于经皮配方的平台(ptf) - Google Patents

用于经皮配方的平台(ptf) Download PDF

Info

Publication number
CN1665492A
CN1665492A CN038151030A CN03815103A CN1665492A CN 1665492 A CN1665492 A CN 1665492A CN 038151030 A CN038151030 A CN 038151030A CN 03815103 A CN03815103 A CN 03815103A CN 1665492 A CN1665492 A CN 1665492A
Authority
CN
China
Prior art keywords
compositions
medicine
paster
ptf
lecithin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN038151030A
Other languages
English (en)
Chinese (zh)
Inventor
尤瓦·西姆哈·蓝德夏夫特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Holden Development Ltd
Original Assignee
Holden Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holden Development Ltd filed Critical Holden Development Ltd
Publication of CN1665492A publication Critical patent/CN1665492A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN038151030A 2002-06-27 2003-06-21 用于经皮配方的平台(ptf) Pending CN1665492A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10228680A DE10228680A1 (de) 2002-06-27 2002-06-27 Grundlage für transdermale Formulierungen (PTF)
DE10228680.9 2002-06-27

Publications (1)

Publication Number Publication Date
CN1665492A true CN1665492A (zh) 2005-09-07

Family

ID=29761469

Family Applications (1)

Application Number Title Priority Date Filing Date
CN038151030A Pending CN1665492A (zh) 2002-06-27 2003-06-21 用于经皮配方的平台(ptf)

Country Status (14)

Country Link
US (1) US20050118241A1 (https=)
EP (1) EP1515706A2 (https=)
JP (1) JP2005535635A (https=)
KR (1) KR20050027995A (https=)
CN (1) CN1665492A (https=)
AR (1) AR040287A1 (https=)
AU (1) AU2003252459A1 (https=)
CA (1) CA2490022A1 (https=)
DE (1) DE10228680A1 (https=)
MX (1) MXPA04012732A (https=)
MY (1) MY157852A (https=)
TW (1) TW200500093A (https=)
WO (1) WO2004002444A2 (https=)
ZA (1) ZA200500710B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20120283332A1 (en) * 2009-05-12 2012-11-08 Ohio University Transdermal delivery of metformin
WO2010141956A2 (en) * 2009-06-05 2010-12-09 Caron Joan M Methods and compositions for the treatment of cancer
US20150297725A1 (en) * 2012-07-30 2015-10-22 Rutgers, The State University Of New Jersey Cochleates made with soy phosphatidylserine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
JPS63316737A (ja) * 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
AU667483B2 (en) * 1991-07-26 1996-03-28 Smithkline Beecham Corporation W/O microemulsions
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
WO1996010439A1 (en) * 1994-09-30 1996-04-11 Kabushiki Kaisya Advance Interface for iontophoretic percutaneous administration, and agent and method for treating the skin for that purpose
US5707641A (en) * 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US6183758B1 (en) * 1998-01-29 2001-02-06 Highland Laboratories, Inc. Phytochemicals, nutrients & medication absorption &/or treatment
AU4972599A (en) * 1998-07-07 2000-01-24 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
BR0010354A (pt) * 1999-05-07 2002-03-05 Pharmasol Gmbh Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

Also Published As

Publication number Publication date
ZA200500710B (en) 2005-09-05
US20050118241A1 (en) 2005-06-02
KR20050027995A (ko) 2005-03-21
JP2005535635A (ja) 2005-11-24
CA2490022A1 (en) 2004-01-08
WO2004002444A3 (en) 2004-03-11
WO2004002444A2 (en) 2004-01-08
EP1515706A2 (en) 2005-03-23
DE10228680A1 (de) 2004-01-22
MXPA04012732A (es) 2005-11-17
MY157852A (en) 2016-07-29
TW200500093A (en) 2005-01-01
AR040287A1 (es) 2005-03-23
AU2003252459A1 (en) 2004-01-19

Similar Documents

Publication Publication Date Title
CA2882048C (en) Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
RU2282468C2 (ru) Устройство для трансдермальной доставки лекарственных средств, имеющее микровыступы с покрытием
US5574006A (en) Nasally administrable peptide compositions on hydroxyapatite carriers
RU2477136C2 (ru) Алкалоидные составы
TWI343263B (en) Patches for mucosa of oral cavity containing fentanyl
KR20070042172A (ko) 레보도파의 주입 용액 및 주사 용액
JPH09509136A (ja) 免疫増強治療のための薬学的組成物
SK11093A3 (en) Treatment of disease employing hyaluronic and nsaids
JP2006522822A (ja) アルコールを含まない経皮インスリン組成物およびその製造工程ならびに使用
CN1665492A (zh) 用于经皮配方的平台(ptf)
US6716877B2 (en) Method to treat chronic heart failure and/or elevated cholesterol levels
DE69733575T2 (de) Verfahren und mittel zur schmerzbehandlung
JP2010514789A (ja) 副腎皮質ステロイド投与のための経皮的方法及びパッチ
RU2232501C2 (ru) Способ повышения естественной резистентности животных
WO2016011104A1 (en) Homeopathic topical gel for transdermal delivery of colchicine formulations and method of use
RU2019180C1 (ru) Средство для лечения подкожной фибросаркомы и способ его получения
KR20190117318A (ko) 우수한 안정성을 갖는 데옥시콜린산 함유 주사제 조성물 및 이의 제조방법
US8323687B2 (en) Pharmaceutical composition for the prevention and treatment of bone tissue resorption of various etiology
CN108553639B (zh) 一种壳聚糖/胰岛素纳米缓释经皮制剂及其制备方法
CN1291862A (zh) 含苯甲酰苯脲的杀真菌组合物
TWI921816B (zh) 一種生物複合體與其衍生之微胞複合物及其製備方法
CN105982882A (zh) 一种光学活性原料组合物组方治疗痔疮的外用药及制备工艺
JP2734554B2 (ja) インスリン様成長因子ｉの点鼻用液剤
CN101036660A (zh) 一种雌激素凝胶药物及其制备方法
JPS6045161B2 (ja) 熱傷の治療剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication